SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-007081
Filing Date
2018-08-14
Accepted
2018-08-14 16:27:13
Documents
67
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mer-20180630x10q.htm 10-Q 1422705
2 EX-10.1 mer-20180630ex10176898a.htm EX-10.1 83390
3 EX-31.1 mer-20180630ex31164e361.htm EX-31.1 11344
4 EX-31.2 mer-20180630ex3125b2c48.htm EX-31.2 13052
5 EX-32.1 mer-20180630ex321e34aa0.htm EX-32.1 16006
  Complete submission text file 0001558370-18-007081.txt   7035823

Data Files

Seq Description Document Type Size
6 EX-101.INS mer-20180630.xml EX-101.INS 1651589
7 EX-101.SCH mer-20180630.xsd EX-101.SCH 63860
8 EX-101.CAL mer-20180630_cal.xml EX-101.CAL 42168
9 EX-101.DEF mer-20180630_def.xml EX-101.DEF 229247
10 EX-101.LAB mer-20180630_lab.xml EX-101.LAB 468422
11 EX-101.PRE mer-20180630_pre.xml EX-101.PRE 351932
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 181017994
SIC: 2834 Pharmaceutical Preparations